Cargando…
Population Pharmacokinetics of Rezafungin in Patients with Fungal Infections
Rezafungin is a novel antifungal agent of the echinocandin class with potent activity against species of Candida and Aspergillus, including subsets of resistant strains, and Pneumocystis jirovecii. The objective of this analysis was to develop a population pharmacokinetic (PK) model to characterize...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522775/ https://www.ncbi.nlm.nih.gov/pubmed/34398673 http://dx.doi.org/10.1128/AAC.00842-21 |